Carulli Michael 4
4 · PMV Pharmaceuticals, Inc. · Filed Jan 22, 2024
Insider Transaction Report
Form 4
Carulli Michael
Chief Financial Officer
Transactions
- Award
Common Stock
2024-01-18+82,220→ 91,286 total - Award
Employee Stock Option (right to buy)
2024-01-18+204,630→ 204,630 totalExercise: $1.80Exp: 2034-01-18→ Common Stock (204,630 underlying)
Footnotes (2)
- [F1]The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 30, 2025.
- [F2]Shares subject to the option vest in 48 equal monthly installments beginning on February 18, 2024.